|
Re: Just back from IR,...
|
2
|
Resverlogix Corp.
|
Oct 29, 2019 10:54AM
|
|
RVX ANNOUNCES TYPE C MEETING WITH FDA FOR CORAL, A PHASE 3 HIGH-RISK COVID-19 OUTPATIENT STUDY
|
2
|
Resverlogix Corp.
|
May 09, 2022 07:42AM
|
|
BTI Share Price in the doldrums
|
2
|
BIOASIS TECHNOLOGIES INC
|
Mar 29, 2019 08:38AM
|
|
Re: RVX Current Status
|
2
|
Resverlogix Corp.
|
Feb 28, 2020 08:01AM
|
|
Re: Major Investors
|
2
|
Resverlogix Corp.
|
Feb 07, 2022 06:29AM
|
|
Re: OTC Trading questions
|
2
|
Zenith Epigenetics
|
Mar 03, 2022 03:52PM
|
|
Re: Another Week
|
2
|
Resverlogix Corp.
|
Oct 21, 2022 05:35PM
|
|
Sept 30 2022 - Resverlogix streaming video
|
2
|
Resverlogix Corp.
|
Sep 30, 2022 06:10AM
|
|
Re: Warrants conversion!
|
2
|
Resverlogix Corp.
|
Nov 26, 2019 12:25PM
|
|
Re: Financing.
|
2
|
BIOASIS TECHNOLOGIES INC
|
May 07, 2019 05:05AM
|
|
Re: ​almost a 32% drop on the rvxcf shot position over the last two reports.
|
2
|
Resverlogix Corp.
|
Jun 05, 2023 04:11PM
|
|
ZEN-3694 in combination with "enzalutamide" in patients with metastatic castration resistant prostate cancer (mCRPC)
|
2
|
Zenith Epigenetics
|
Aug 27, 2021 12:56PM
|
|
Re: Shawn lu RSU and option cancelled
|
2
|
Resverlogix Corp.
|
Apr 07, 2020 01:43PM
|
|
Re: Still Waiting
|
2
|
BIOASIS TECHNOLOGIES INC
|
Feb 09, 2024 06:36AM
|
|
Re: 2023 Outlook per MD&A
|
2
|
Resverlogix Corp.
|
Apr 09, 2023 07:20AM
|
|
Re: Next private placement/licensing agreement
|
2
|
Resverlogix Corp.
|
Feb 06, 2019 05:27PM
|
|
Re: Resverlogix Announces Voting Results from the 2024 Meeting of Shareholders and Closing of Debenture Extension
|
2
|
Resverlogix Corp.
|
Aug 01, 2024 11:34AM
|
|
Re: According to the TMX website there are only 5 million RVX.WT.A oustanding....
|
2
|
Resverlogix Corp.
|
Jun 20, 2019 05:40PM
|
|
Re: Meanwhile back at the outhouse, things are piling up....no tweet about the AGM
|
2
|
Resverlogix Corp.
|
Aug 24, 2019 12:45PM
|
|
Re: CNBC at the JPM Bio Tech Conference
|
2
|
Resverlogix Corp.
|
Jan 08, 2019 02:50PM
|
